ARTICLE | Emerging Company Profile
Aerium: taking on COVID variants and pandemic preparedness
Omega’s Aerium is the latest COVID-19 mAb play, but it has broader pandemic preparedness ambitions and in Rajeev Venkayya a CEO to match
March 22, 2022 12:02 PM UTC
With a pair of prophylactic mAbs for COVID-19 with activity across variants, backing from Omega Funds and pandemic response policy leader Rajeev Venkayya at the helm, new biotech Aerium is taking on the big challenges of COVID-19 therapeutic development and pandemic preparedness.
Aerium Therapeutics Inc. emerged from stealth on Tuesday with a series A round of undisclosed size from Omega Funds, which seeded and incubated the company over the past year. F-Prime Capital also participated...